Cancel

Diagnosis and Evidence-based Prevention of Chronic Obstructive Pulmonary Disease Exacerbations

Target Audience The primary target audience for this activity are Pulmonology clinicians (MDs/DOs/NPs/PAs) based in the U.S. Program Overview Many patients do not receive appropriate and timely treatment for chronic obstructive pulmonary disease (COPD) because of underdiagnoses, diagnostic delays, or misdiagnoses as other respiratory conditions such as asthma. An expert panel of pulmonologists will identify and address important gaps in the differential diagnosis and management of COPD. O...
Partners for Advancing Clinical Education (PACE) and PlatformQ Health Education, LLC, in collaboration with COPD Foundation and the Association of Pulmonary Advanced Practice Providers (APAPP).

Managing Obesity in Adolescent Patients Your Top 10 Questions Answered

The rate of obesity in children and adolescents is increasing, posing significant physical and mental health challenges through childhood and adolescence and into adulthood. Recently, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have been approved for use in patients as young as 12 years, and it is critical that clinicians initiate both lifestyle management and pharmacologic therapies as early as possible. Dr. Fatima Stanford discusses 10 common questions asked about managing obesity ...
Integritas Communications

Making The Call in Lower-Risk MDS Exploring Treatments That Improve Outcomes & Decrease Transfusion Burden

Myelodysplastic syndromes (MDSs) are among the most common hematologic malignancies and are characterized by their risk of progression to acute leukemia. Although patients with lower-risk MDS (LR-MDS) have longer life expectancies compared to those with high-risk disease, their disease course is not without challenges. In fact, symptoms related to anemia are very common in this population and lead to poor quality of life. Fortunately, therapies are now available to treat the anemia associated ...
Integritas Communications

Introduction to Orofacial Myofunctional Therapy - Licia Coceani Paskay, MS, CCC-SLP and Joy L. Moeller, BS, RDH

The speech pathologist will be able to understand what oral myofunctional disorders are and why they are detrimental to patients, the history of the profession, learn an overview of assessment and etiology, what the goals of treatment are, possible members of the team needed to treat the disorders, and view some case studies. It also contains a review of both anatomy and physiology of the orofacial complex is intended to bring all attendees at a common level of knowledge, granted that each pro...
Speech Therapy Professional Development

Treating Orofacial Myofunctional Disorders: Beyond the Symptoms - Linda D'Onofrio, MS, CCC-SLP

This 2-day workshop is an advanced survey course, in orofacial myofunctional disorders (OMDs) for the experienced medical professional whose scope of practice intersects in the orofacial complex. Differential diagnosis and feeding, swallowing, and communication techniques will be featured throughout the workshop that can be incorporated into therapy immediately.
Speech Therapy Professional Development

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map